Administration of peroxisomal proliferator-activated receptor (PPAR) agonist pioglitazone before, during, and for 4 weeks postirradiation can prevent cognitive impairments, but starting administration 24 h after BI is ineffective [34]. This evidence concerns the gene PPARA and Cognitive impairment.